Ezagoo LTD

Market Movers (8-K)

OTC.Pink
EZAGOO Limited has dismissed its previous auditor, TAAD LLP, and appointed Enrome LLP as its new independent registered public accounting firm, effective February 5, 2024.

Quarterly Earnings (10-Q)

OTC.Pink
Ezagoo Limited reported a net loss of $332,448 for the nine months ended September 30, 2025, with revenues decreasing by 36.6% and significant going concern uncertainties.
Capital raise
Worse than expected
OTC.Pink
Ezagoo Limited reported a significant increase in net and comprehensive losses for the six months ended June 30, 2025, alongside persistent going concern uncertainties and ineffective internal controls.
Worse than expected
Capital raise
OTC.Pink
Ezagoo Limited's latest quarterly report reveals a significant 58.8% drop in revenue and a 37.4% increase in net loss, exacerbating its substantial accumulated deficit and raising going concern uncertainties.
Worse than expected
Capital raise
OTC.Pink
Ezagoo Limited's Q3 2024 results show a decrease in revenue and an increase in net loss compared to the same period last year, alongside a growing working capital deficit.
Worse than expected
OTC.Pink
Ezagoo Limited's Q2 2024 results show a decrease in revenue compared to the same period last year, but a reduced net loss.
Worse than expected
OTC.Pink
Ezagoo Limited's Q1 2024 results show a decrease in revenue compared to the same period last year, but also a significant reduction in net loss.
Worse than expected

Annual Reports (10-K)

OTC.Pink
Ezagoo Limited's 2024 annual report reveals a net loss, strategic shifts due to market competition and COVID-19, and ongoing efforts to navigate regulatory complexities in China.
Worse than expected
OTC.Pink
Ezagoo Limited's 10-K filing reveals a strategic shift from advertising to e-commerce and health-related products, alongside financial details and risk factors.
Capital raise
Worse than expected